AGRF and the Centre for Population Genomics announce a partnership to deliver whole-genome sequencing for OurDNA, Australia's national program to build a genomic resource that reflects the true diversity of Australian communities.
Read MorePostpartum depression (PPD) affects 1 in 5 mothers globally and is a leading cause of maternal death—yet there’s still no reliable clinical test to identify those at risk. Current screening relies on self-reported questionnaires, which often miss or misdiagnose many women.
Ketim Technologies is changing that by developing the world’s first blood-based diagnostic test for PPD. By analysing protein biomarkers with support from AGRF and Olink proteomics, they aim to bring objective, early detection into maternal mental health care.
Driven by both science and lived experience, CEO Clarissa Yates is leading this breakthrough initiative to ensure more mothers get timely, accurate support—transforming care for families, clinicians, and communities alike.
Read MoreNeurodevelopmental disorders (NDDs) represent a significant global health challenge, affecting millions of children worldwide. Understanding the biological basis of these complex disorders is key to developing treatments, with tools like transcriptomics and proteomics offering valuable molecular insights.
Read MoreAssociate Professor Sarah Auburn, a molecular biologist at Menzies School of Health Research, leads global efforts to combat malaria through genomic surveillance of Plasmodium vivax, leveraging international collaboration and support from AGRF to develop high-throughput genotyping tools that inform targeted interventions in endemic regions.
Read MoreMelanoma is the third most common cancer in Australia, with an average of one person diagnosed every 30 minutes.
Read MoreAGRF, in partnership with CRC-TiME and Indigenous communities, is using genomic technologies to support climate-resilient mine rehabilitation in Australia.
Read MoreSince 2021, AGRF has been a key partner in the Zero Childhood Cancer Program (ZERO), Australia’s first precision medicine initiative for children with cancer. AGRF provides vital multi-omic sequencing data for each child, which helps inform personalised treatment plans.
Read MoreTraditionally plant research has relied on a single reference genome, the field is now advancing toward pangenomics, creating multiple reference genomes to capture the full genetic diversity of a species.
Read MoreWestern Australia is known for its breath-taking landscapes, but behind the scenes, strict biosecurity measures protect its agriculture and environment from pests and pathogens. While quarantine bins and detection dogs at the airport may go unnoticed by most, these defences are vital in keeping the state safe.
Read MoreEpigenetics offers a promising approach to our understanding of how environmental factors can impact gene expression and contribute to the risk of chronic conditions.
Read MoreOver the past two decades, Australian dryland broadacre farms have experienced significant changes in farming practices and climatic conditions, including the introduction of “No Till” farming.
Read MoreAGRF is partnering with SeonixBio to support the development and clinical implementation of a genetic risk prediction test for glaucoma. Assessing genetic risk of developing glaucoma will enable individuals to monitor for symptoms and make treatment decisions.
Read MoreAGRF plays a crucial role by providing genomic sequencing and analysis to patients with upcoming transplant procedures.
Read MoreThe Weedy Seadragon is a camouflaged fish found in the southern temperate waters of Australia from the central NSW coast around the south coast of Australia to south-western WA. Genetic data collected will be important for environmental researchers and ecologists to consider.
Read MoreNative stingless bees, are now recognised not only for their ecological role but also as reservoirs of microbial biodiversity with potential biotechnological applications.
Read MoreAs climate change intensifies environmental pressures, researchers are turning to genetic studies to understand how species adapt to shifting conditions.
Read MoreScientists often describe DNA as the blueprint of life. If this is true, then proteins are the bricks, mortar, timber, glass, cables, pipes, plaster and paint. And just as you study the blueprints with genetics and genomics, you study these building materials with proteomics.
Read MoreWestern Australia's stunning and diverse landscapes are home to an incredible array of invertebrate species. To help uncover and document this biodiversity, the innovative WA Bug Barcode Blitz program has emerged. As part of National Science Week, this program engages students and the community in STEM learning experiences and deepen their understanding of global diversity loss.
Read MoreAGRF’s genomic data is helping researchers explore the connections between gut health, gut microbiota and brain health, particularly in relation to stress and depression.
Read More“Our aim is to utilise microorganisms, especially fungi, to capture carbon from the atmosphere and return it to the soil.” Abed Chaudhury.
Read more
Read MoreExplore our latest News and Media
We are committed to delivering exceptional services to healthcare providers and research partners, all of the time.
If you have any questions, comments or concerns, please let us know.
Contact our Customer Care Team
Freecall 1300 247 301
Phone +61 3 9321 3700
CustomerCare@agrf.org.au
Please note: We do not offer genetic services or consultation to the public. Our genetic sequencing solutions are available exclusively through healthcare providers and research partners.
View our Annual Report for Financial Year 2024-25
AGRF respectfully acknowledge the Aboriginal and Torres Straight Islander people as the Traditional Owners of the land on which we work and live, and we pay our respects to their Elders past and present.
We respect and recognise their continuing connection to Country and land, water and community.
AGRF Ltd.
ABN - 63 097 086 292
Please note: We do not offer genetic services or consultation to the public. Our genetic sequencing solutions are available exclusively through healthcare providers and research partners.
